FDA

Special Section 

The Future of Healing

July 1, 2017July 28, 2017 Donna Ison adhesion, advanced endometriosis, amniotic fluid, BioD, biological patch, birth tissue, clinical application, debilitate pelvic pain, debilitate pelvic pain of pudendal neuralgia, employment of amniotic fluid, endometriosis, FDA, fear of the patient, fluid, groundbreaking application, gynecology, Karon, Karon state, Magdalene Karon, mother nature, nationwide apply regenerative medicine, neuralgia, new application, pain, pelvic prolapse procedure, placental tissue, prolapse procedure, pudendal, pudendal neuralgia, regenerative source, risk of adhesion, synthetic-made, tissue, tissue regeneration, treatment of advanced endometriosis, use of amniotic fluid, word of Karon

LEXINGTON After 30 years of private practice as an OB/GYN, Magdalene Karon, MD, decided to supplement her practice and get

Read more

Cardiology Heart & Lung Special Section 

A New Home for Structural Heart Disease

April 1, 2017July 17, 2017 Bob Baker anesthesia, anesthesiologist, anesthesiology, Anne Marie Webb, aortic stenosis, aortic valve replacement, APRN, BSN, cardiac anesthesia, cardiac anesthesiologist, cardiologist, cardiology, cardiothoracic, cardiothoracic surgeon, cardiovascular surgeon, CCRN, clinical cardiac operation, clinical research coordinator, coordinator, director of clinical cardiac operation, Erika Keithley, FDA, Flaherty, FNP-BC, Genny Sanders, Grubb, heart center, heart disease program, heart program, heart surgery, interventional cardiologist, interventional cardiology, invasive technique, Jewish hospital, KentuckyOne, KentuckyOne health, Louisville, low-risk patient, Matthew Williams, medical director, medical director of the structural heart program, Michael Flaherty, MitraClip, mitral regurgitation, MSN, multidisciplinary team, Naresh Solankhi, nurse, nurse navigator, open heart surgery, photo, physician, provider, regurgitation, research coordinator, risk patient, RN, Sharon Vincent, stenosis, structural heart center, structural heart disease, structural heart disease program, structural heart program, surgeon, surgery, surgical director, surgical director of the structural heart program, TAVR, TAVR procedure, TAVR program, team approach, therapy, transcatheter, U, valve, valve coordinator, valve replacement, valvular disease

LOUISVILLE They say, “Home is where the heart is.” Well, now the heart has a new home – at the

Read more

Cardiology Heart & Lung Special Section 

Building a Structural Heart Program

April 1, 2017July 17, 2017 Donna Ison Abdelkader Almanfi, Al-Arab, Al-Arab medical university, Almanfi, Almanfi 's passion, aneurysm, artery, big need, blood flow, blood thinner, cardiologist, cardiology, cardiology fellowship, cardiology innovation facility, catheter, choice of specialty, dedicated group of specialist, Dr. Abdelkader Almanfi, endovascular, endovascular aneurysm repair, FDA, fellow cardiologist, femoral, field of cardiology, full potential, groin, heart care, heart disease, heart program, heart surgery, heart team, hospital administration, image expert, internal medicine residency, interventional cardiologist, interventional cardiology fellowship, medicine residency, mitral valve regurgitation, open heart surgery, organization-wise, outside of coronary artery, Owensboro, Owensboro health, Owensboro many physician, physician, post-doctoral cardiology fellowship, premier cardiology innovation facility, procedure, regurgitation, specialty-wise, structural cardiology, structural heart disease, structural heart program, structural heart team, surgery, TAVR, teamwork, Texas heart institute, thinner, transcatheter, treatment of structural heart disease, valve, valve condition, valve coordinator, valve regurgitation, valve replacement, vascular intervention, watchman

OWENSBORO Many physicians can point to a mentor or a singular event during their training that influenced their choice of

Read more

Pain Management Special Section 

A New Era in Pain Management is Brought on by New Technology

February 1, 2017July 17, 2017 Gil Dunn ablation, anesthesiology, area of pain, Axium, Axium™ Neurostimulator, Axium™ Neurostimulator system, cancer pain patient, Care, clinic, collection of sensory nerve, common presentation of pain, complex regional pain syndrome, comprehensive pain care, cord, cord stimulation, cord stimulator, CRPS, degeneration of the spine, dorsal root ganglion, DRG, DRG stimulation, FDA, FDA approval, final FDA approval, game changer, ganglion, genicular, genicular nerve ablation, hand of interventional pain management physician, interventional nerve block, interventional pain management physician, Joseph, Joseph hospital, Karim Rasheed, Kentucky medical center, KentuckyOne, KentuckyOne health pain, knee, knee replacement surgery, mixture of opioid, modality, myofascial, neck, nerve, nerve block, neuropathic condition, next generation of spinal cord stimulation, non-opioid, non-opioid treatment, oral-facial pain, orthopedic surgeon, osteoarthritis, pain, pain blockage, pain care, pain clinic, pain management, pain management physician, pain relief, pain syndrome, physical therapy, precise lead, Rasheed, Rasheed 's practice, relief, root ganglion, specific region of the spinal cord, spinal cord, spinal cord stimulator, St. Jude, St. Jude medical website, stimulation, stimulator, surgery, syndrome, targeted pain blockage, therapy, traditional spinal cord stimulation, treat neck, university of Kentucky medical center

LEXINGTON After nearly 25 years of medical training and practice, Karim Rasheed, MD, knows a game changer when he sees

Read more

Cancer Care Cover Story Oncology 

Focal Point

October 1, 2016July 17, 2017 Jennifer S. Newton advantage of HIFU, advent, aggressive prostate cancer, antigen, Bahamas, biopsy, bladder, board-certified, board-certified urologist, Brooks Jackson, cancer, cancer cell, Cancun, cure cancer, cure rate, dysfunction, Eifler, erectile, erectile dysfunction, erectile function, family history, family history of prostate cancer, FDA, focal HIFU, focal point, Gleason, graduate of the U, group of local urologist, HIFU, HIFU promise result equal, HIFU prostate service, HIFU surgeon, HIFU treatment center, high intensity, high risk, HPS, HPS Kentucky, incontinence, intensity, international locale, Jackson, John Jurige, Jurige, Kentucky, leading-edge, leading-edge therapy, life alter side effect, local urologist, Louisville, medical school, metro urology, MRI, oncology, option, outcome, outpatient, outpatient procedure, outpatient procedure use ultrasound energy, photo, physician, probe, procedure, proctor, prostate, prostate cancer, prostatectomy, PSA, PSA screen, radiation, radiation therapy, radical prostatectomy, residency, Robert Densmore, school of medicine, screen, side effect, Sonablate® HIFU, spare normal tissue, specialized ultrasound probe, specific antigen, surgeon, surgery, survival, therapy, three-dimensional image, three-dimensional image of the prostate, tissue, traditional treatment, traditional treatment of radical prostatectomy, treatment option, U, ultrasound, ultrasound energy, ultrasound probe, urinary incontinence, urologic, urologist, urology, visualization

LOUISVILLE When I think of Nassau, Bahamas, and Cancun, Mexico, I picture white sand beaches, crystal blue waters, and vacation

Read more

Cancer Care Headlines Oncology 

A Single Breath

July 1, 2016July 17, 2017 MD-Update Staff balloon, Berkel, breath, breath analysis, breath test, cancer, carbonyl, CT, early diagnosis of lung cancer, exhaled breath, FDA, lab, lab test, Louisville, Louisville researcher, lung, lung cancer, lung cancer patient, M., M. Schumer, microchip, next step, patient blow, primary screen tool, pump, recurrence, recurrent lung cancer, researcher, return of lung cancer, Schumer, signature 's present, single breath, small microchip, specialized balloon, surgery, U, university of Louisville researcher, van, VOCs

LOUISVILLE A single breath may be all it takes to identify the return of lung cancer after surgery, according to

Read more

Cover Story 

The Patient Is Paramount

May 1, 2015 Jennifer S. Newton advanced technology make, baptist health, baptist health team, baptist OB, booth, Brian Bohannon, Brian Bohannon Dr. Rebecca Booth, Brown, cancer, cervix, change dynamics of medicine, co-managing, co-managing partner, co-managing partner of woman, common surgical procedure, complication, Dr. Heath Brown, educate patient, experienced gynecologic surgeon, fallopian tube, FDA, fibroids, forefront, good interest, good interest of patient, GYN, GYN associate, GYN group serve baptist health, gynecologic, gynecologic surgeon, gynecologic surgery, gynecologist, gynecology, harmonic scalpel, HHS office, hospital stay, hysterectomy, in-office, incision, incontinence, invasive approach, invasive gynecologic surgery, invasive option, invasive surgery, invasive technique, laparoscopic, laparoscopic hysterectomy, large abdominal incision, large OB, LAVH, ligament, Louisville, Louisville consumer-driven healthcare, MIS, MIS technique, model of care, morcellation, morcellator, OB, open hysterectomy, open surgery, option, ovarian conservation, ovary, partial cause, pearl, photography, physician, post-operative, procedure, prolapse, quick recovery, Rebecca Booth, reimbursement rate, residency, robotic, sarcoma, scalpel, short hospital stay, supracervical, supracervical hysterectomy, surgeon, surgery, technology make, TLH, tool, total laparoscopic hysterectomy, treatment option, tube, TVH, U, university of Louisville, uterosacral, uterosacral ligament, uterus, vagina, vaginal hysterectomy, warren, woman 's health

LOUISVILLE Consumer-driven healthcare, a model of care that puts the patient at the center, has become the rallying cry across

Read more

Special Section 

The Beat Goes On

March 1, 2015 Jim Kelsey aortic stenosis front, appendage, atrial fibrillation, beat, blood thinner, cardiac patient, cardiologist, cardiology, changer, co-director, CoreValve, Dermot Halpin, Edwards SAPIEN Transcatheter, Edwards SAPIEN Transcatheter heart, executive co-director, executive co-director of KentuckyOne health heart, FACC, FACS, failure, Falluji, FDA, FDA approval, fibrillation, FSCAI, game changer, grow collaboration, Hamid Mohammadzadeh, heart team, heart team 's approach, invasive procedure, Joseph, Joseph hospital, Joseph hospital heart team handle technology change, KentuckyOne, KentuckyOne health cardiology associate, KentuckyOne health heart, lariat, lariat procedure, Lexington, MD-UPDATE, MD-UPDATE issue, Michael Schaeffer, mitral valve, new procedure, Nezar Falluji, noose, percutaneous valve team, procedure, regurgitation, Robert Salley, sheath size, size of the delivery system, small sheath size, stenosis front, symptom, thinner, unique team approach, valve, valve team, vascular care

LEXINGTON In February 2014, MD-UPDATE Issue #84 shared the story of the “Heart Team” at KentuckyOne Health Cardiology Associates at

Read more

Cancer Care Cover Story Oncology 

Game Changer

July 1, 2014July 17, 2017 Jennifer S. Newton 30 to 40 % response rate, A., antibody, autoimmune, Bristol-Myers Squibb, broad clinical trial program, brown cancer center, cancer, cancer center, cancer patient, carcinoma, cell carcinoma, changer, checkpoint, checkpoint protein, Chesney, clinical trial, clinical trial center, community oncology center, CTLA-4, dose-escalation, Dr. Jason Chesney, early access, FDA, FDA approval, FDA-approved, FDA-approved drug, game changer, health care access, immune checkpoint protein, immune system, immunotherapy, imperative message, improvement, infusion, inhibitor, ipilimumab, Ipilimumab work, James Graham Brown, James Graham Brown cancer center deputy director, Jason A., Kentucky, KentuckyOne, KentuckyOne health, Louisville university, Louisville university of Louisville 's, lung, lung cancer, melanoma, melanoma patient, Merck, new class, new class of drug, Nivolumab, oncology, overall survival, patient access, PD-1, PD-1 inhibitor, PD-L1, pembrolizumab, PFK-158, phase 1/2, phase 1/2 dose-escalation trial, pretty compel, protein, renal cell carcinoma, response rate, stage 4, stage 4 cancer, stage 4 melanoma, stage 4 melanoma patient, standard FDA-approved drug, survival, survival data, survival rate, therapy, trial center, tumor, U, Yervoy®

LOUISVILLE University of Louisville’s (U of L) James Graham Brown Cancer Center Deputy Director Jason A. Chesney, MD, PhD, has

Read more

Physician Viewpoint 

Is There a Method to This Madness?

March 1, 2014 James Patrick Murphy, MD, MM acetaminophen, addiction, addiction medicine, advantage of a delivery system, APAP, around-the-clock pain, available opioid, Avinza, cause liver failure, effective opioid, extended-release, extended-release drug, extended-release hydrocodone pill, FDA, FDA conspiracy, Focalin XR, hard-copy prescription, hydrocodone, hydrocodone extended-release, hydrocodone-APAP, hydrocodone-APAP combination, hydrocodone-APAP pill, leader 's concern, legitimate worry, long-lasting version, madness, medical lifetime, morphine, new hard-copy prescription, Opana ER, Opioid, opioids, oxymorphone, pain, pain pill, physician, pill, popular tamper-resistant technology, practical purpose, prescribed opioid, real villain, reformulation, Ritalin LA, schedule-three, schedule-three drug, schedule-two, schedule-two drug, short-acting pill form, tamper-resistant, tamper-resistant technology, villain, worry of mass, Zohydro ER

In March 2014, Zohydro ER (hydrocodone extended-release) was introduced to the market. Never in my medical lifetime do I recall

Read more